Spero Therapeutics, Inc. (SPRO) News Headlines

▮ More

Date

Headline

5/27/2022 10:04:02 AM Biotech Stocks Facing FDA Decision In June 2022

5/3/2022 9:16:29 AM Why Spero Therapeutics Stock Falling In Pre-market?

5/3/2022 8:24:20 AM Spero Therapeutics Announces Immediate Cessation Of Tebipenem HBr Commercialization Initiatives; To Cut 75% Of Staff

4/1/2022 5:31:34 AM TRVN To Report Data In Mid-year, TSHA Trims Workforce, FDA Decision On SPRO's NDA To Be Delayed?

1/19/2022 8:43:53 AM Spero Awarded Up To Addl $12.9 Mln By BARDA To Support Development Of Tebipenem Pivoxil In Pediatric Patients

1/4/2022 8:43:34 AM Spero Therapeutics Says FDA Lifts Clinical Trial Hold On SPR720 - Quick Facts

1/4/2022 8:27:34 AM Spero Therapeutics Reports Lifting Of FDA Clinical Trial Hold On SPR720

1/3/2022 8:56:13 AM Spero's New Drug Application For Tebipenem HBr Tablets Granted Priority Review

7/5/2021 6:44:47 AM Everest Medicines: Spero Therapeutics, Pfizer In Deal For SPR206 In Ex-U.S. And Ex-Asia Territories

7/5/2021 6:06:48 AM Spero Therapeutics Enters Licensing Agreement With Pfizer For SPR206 In Ex-U.S. And Ex-Asia Territories

7/1/2021 10:41:20 AM Spero Therapeutics Adds 14% Following $40 Mln Investment By Pfizer

2/5/2021 8:19:20 AM Spero Therapeutics Says FDA Placed Clinical Hold On Phase 2a Clinical Trial Of SPR720

3/6/2014 4:47:32 PM SmartPros Ltd. (SPRO) Declares Quarterly Dividend of $ 0.015 , Record Date 3/21/2014

3/8/2012 5:10:54 PM SmartPros Ltd. (SPRO) Declares Quarterly Dividend of $ 0.0125, Record Date 3/22/2012

8/9/2011 4:54:56 PM SmartPros Ltd. (SPRO) Declares Quarterly Dividend of $ 0.0125, Record Date 9/16/2011

11/9/2010 5:05:48 PM SmartPros Ltd. (SPRO) Announces $750K Stock Buyback

11/9/2010 5:04:43 PM SmartPros Ltd. (SPRO) Declares Quarterly Dividend of $ 0.01, Record Date 12/15/2010

Older Articles